Expression and Clinical Significance of ILF2 in Gastric Cancer

Table 1

Relationship between ILF2 expression and clinicopathological parameters ().

Parameters	ILF2 expression
	High ()	Low ()	X^2	value
Gender
Male	21	13	0.000	0.986
Female	16	10
Age (years)
>60	19	14	0.519	0.471
≤60	18	9
Location
Cardia	19	12	0.004	0.951
Body/antrum	18	11
Size (cm)
>5	13	9	0.097	0.755
≤5	24	14
Histological differentiation
Well/moderate	7	15	13.092	0.000
Poor/not	30	8
Depth of invasion (T classification)
T1/T2	6	9	3.972	0.046
T3/T4	31	14
Lymph node metastasis
No	10	14	6.769	0.009
Yes	27	9
Surgical resection
Partial	10	7	0.081	0.776
Total	27	16
TNM stage
I/II	9	16	11.944	0.001
III/IV	28	7
CA19-9
Positive	13	6	0.537	0.464
Negative	24	17
CEA
Positive	13	7	0.141	0.707
Negative	24	16
CA125
Positive	12	6	0.272	0.602
Negative	25	17

TNM: tumor node metastasis; and was defined as statistically significant.